Should You Buy or Sell Entrada Therapeutics Stock? Get The Latest TRDA Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Rating)’s share price shot up 5.2% on Thursday . The stock traded as high as $17.25 and last traded at $16.78. 32,295 shares were traded during mid-day trading, a decline of 32% from the average session volume of 47,732 shares. The stock had previously closed at $15.95. Entrada Therapeutics […]
Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Rating) were up 5.2% during trading on Thursday . The company traded as high as $17.25 and last traded at $16.78. Approximately 32,295 shares changed hands during mid-day trading, a decline of 32% from the average daily volume of 47,732 shares. The stock had previously closed at […]
27.02.2023 - BOSTON, Feb. 27, 2023 (GLOBE NEWSWIRE) - Entrada Therapeutics, Inc. (Nasdaq: TRDA), a biotechnology company aiming to transform the lives of patients and become the world’s foremost intracellular therapeutics company by establishing Endosomal .
09.02.2023 - - Global collaboration includes ENTR-701, Entrada’s late-stage preclinical candidate for the treatment of DM1 - - Company’s cash runway extended into the second half of 2025 - BOSTON, Feb. 09, 2023 (GLOBE NEWSWIRE) - Entrada Therapeutics, Inc. . Seite 1